These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21806448)

  • 41. The effect on the fetal pituitary-adrenal axis of dexamethasone administration early in the second trimester of pregnancy.
    Mesogitis S; Daskalakis G; Papapetrou P; Mavroudis K; Papandroulaki F; Papantoniou N; Antsaklis A
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):109-12. PubMed ID: 20528220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal treatment of congenital adrenal hyperplasia: author differs with technical report.
    New MI
    Pediatrics; 2001 Apr; 107(4):804. PubMed ID: 11379427
    [No Abstract]   [Full Text] [Related]  

  • 43. Treating fetal thyroid and adrenal disorders through the mother.
    Van Vliet G; Polak M; Ritzén EM
    Nat Clin Pract Endocrinol Metab; 2008 Dec; 4(12):675-82. PubMed ID: 18981991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How safe is long-term prenatal glucocorticoid treatment?
    Seckl JR; Miller WL
    JAMA; 1997 Apr; 277(13):1077-9. PubMed ID: 9091698
    [No Abstract]   [Full Text] [Related]  

  • 45. [The effect of maternal dexamethasone treatment after the 12th week of pregnancy on fetal genital development in adrenogenital syndrome with 21-hydroxylase deficiency].
    Schwab KO; Kruse K; Dörr HG; Horwitz AE; Spingler H
    Monatsschr Kinderheilkd; 1989 May; 137(5):293-6. PubMed ID: 2786992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety.
    Miller WL
    J Urol; 1999 Aug; 162(2):537-40. PubMed ID: 10411085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    New MI; Abraham M; Yuen T; Lekarev O
    Semin Reprod Med; 2012 Oct; 30(5):396-9. PubMed ID: 23044876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and management of congenital adrenal hyperplasia.
    New MI
    Annu Rev Med; 1998; 49():311-28. PubMed ID: 9509266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prenatal diagnosis and therapy of adrenogenital syndrome with 21-hydroxylase deficiency].
    Dörr HG; Sippell WG; Willig RP
    Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):586-8. PubMed ID: 1294431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Congenital adrenal hyperplasia: prenatal and perinatal diagnosis. Early prenatal treatment].
    Forest MG; David M; Betuel H
    Endokrynol Pol; 1986; 37(6):279-86. PubMed ID: 3495428
    [No Abstract]   [Full Text] [Related]  

  • 51. Preventing female virilisation in congenital adrenal hyperplasia: The controversial role of antenatal dexamethasone.
    Heland S; Hewitt JK; McGillivray G; Walker SP
    Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):225-32. PubMed ID: 26661642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal Treatment with Dexamethasone in Suspected Congenital Adrenal Hyperplasia and Orofacial Cleft: a Case Report and Review of the Literature.
    Rijk Y; van Alfen-van der Velden J; Claahsen-van der Grinten HL
    Pediatr Endocrinol Rev; 2017 Sep; 15(1):21-25. PubMed ID: 28845624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a 10 year experience.
    Forest MG; David M
    Indian J Pediatr; 1992; 59(4):515-22. PubMed ID: 1452270
    [No Abstract]   [Full Text] [Related]  

  • 54. [21 hydroxylase deficiency: new strategies emerging from molecular studies].
    Morel Y; Tardy V; Costa JM; Forest MG; David M
    Ann Endocrinol (Paris); 2003 Dec; 64(6):456-70. PubMed ID: 15067252
    [No Abstract]   [Full Text] [Related]  

  • 55. Antenatal diagnosis and treatment of the adrenogenital syndrome.
    Nichols J
    Lancet; 1970 Jan; 1(7637):83. PubMed ID: 4188644
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia.
    Evans MI; Chrousos GP; Mann DW; Larsen JW; Green I; McCluskey J; Loriaux DL; Fletcher JC; Koons G; Overpeck J
    JAMA; 1985 Feb; 253(7):1015-20. PubMed ID: 3968825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Familial congenital adrenal hyperplasia caused by 11 beta-hydroxylase. Failure of prevention of sexual ambiguity and prenatal diagnosis].
    Bouchard M; Forest MG; David M; Dechaud H; Juif JG
    Pediatrie; 1989; 44(8):637-40. PubMed ID: 2622705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification.
    Theodoropoulou M; Barta C; Szoke M; Guttman A; Staub M; Niederland T; Sólyom J; Fekete G; Sasvari-Szekely M
    Fetal Diagn Ther; 2001; 16(4):237-40. PubMed ID: 11399887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S; Clark AT; Freeman LC; Dolan LM; Immken L; Mueller OT; Stiff D; Shulman DI
    J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prenatal diagnosis and treatment of intersex states.
    Rintoul NE; Crombleholme TM
    Adv Exp Med Biol; 2002; 511():225-37; discussion 237-8. PubMed ID: 12575764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.